07:00 , May 2, 2011 |  BioCentury  |  Finance

Anti-anti-wound healing

Conventional wisdom says money spent on chronic wound healing programs is money wasted, but a trio of investors is doubling down on CoDa Therapeutics Inc. based on Nexagon 's performance in a Phase II trial...
07:00 , Apr 25, 2011 |  BC Week In Review  |  Financial News

CoDa Therapeutics completes venture financing

CoDa Therapeutics Inc. , San Diego, Calif.   Business: Dermatology, Ophthalmic   Date completed: 4/18/11   Type: Venture financing   Raised: $19.2 million   Investors: Domain Associates; GBS Venture Partners; BioPacificVentures   Note: CoDa said...
23:59 , Apr 18, 2011 |  BC Extra  |  Financial News

CoDa raises $19.2 million

Wound therapy company CoDa Therapeutics Inc. (San Diego, Calif.) raised $19.2 million in the first tranche of a series B round led by Domain Associates. GBS Venture Partners and BioPacificVentures also participated. CoDa said it...
08:00 , Mar 21, 2005 |  BioCentury  |  Finance

Ebb & Flow

Phase III Avastin data always seem to be good for an $11 billion pop in Genentech's market cap, and the company is two for two on that front. Such was the case in 2003, when...